A compound of formula (I) as defined herein, or a pharmaceutically acceptable salt thereof, being potent modulators of human IL- 17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.
[EN] COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION<br/>[FR] COMPOSÉS UTILISÉS POUR TRAITER UNE INFECTION CINÉTOPLASTIDE
申请人:IRBM SCIENCE PARK S P A
公开号:WO2018115275A1
公开(公告)日:2018-06-28
The present invention relates to a class of novel heterocyclic compounds, to pharmaceutical compositions comprising the compounds and their use in the treatment of kinetoplastid infections.